Elicio Therapeutics
ELTX
Elicio Therapeutics (ELTX) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$0.60
- EPS estimate
- −$0.48
- EPS surprise
- −25.00%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Nov 13, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Nov 13, 2025 | −$0.48 | −$0.60 | −25.00% | $0.00 | SEC |
| Q2 2025 | Aug 7, 2025 | −$0.69 | −$0.66 | +3.65% | $0.00 | SEC |
| Q1 2025 | May 13, 2025 | −$0.83 | −$0.87 | −4.82% | $0.00 | SEC |
| Q4 2024 | Mar 31, 2025 | −$0.88 | −$1.07 | −22.29% | $0.00 | SEC |
| Q3 2024 | Nov 13, 2024 | −$0.73 | −$1.39 | −90.41% | $0.00 | SEC |
| Q2 2024 | Aug 13, 2024 | −$0.96 | −$0.64 | +33.33% | $0.00 | SEC |
| Q1 2024 | May 15, 2024 | −$1.09 | −$1.15 | −5.50% | $0.00 | SEC |
| Q4 2023 | Mar 29, 2024 | −$1.03 | −$1.25 | −21.36% | $0.00 | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.80 | −$1.27 | −58.75% | $0.00 | SEC |
| Q2 2023 | Aug 11, 2023 | −$5.70 | −$2.61 | +54.21% | $0.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$3.20 | −$3.00 | +6.25% | $0.00 | — |
| Q2 2022 | Aug 15, 2022 | −$4.63 | −$3.00 | +35.25% | $653,000.00 | SEC |
| Q1 2022 | May 16, 2022 | −$4.35 | −$4.80 | −10.34% | $1.6M | SEC |
| Q4 2021 | Mar 30, 2022 | −$3.28 | $5.00 | +252.67% | $25.9M | SEC |
| Q3 2021 | Nov 12, 2021 | −$7.25 | −$5.30 | +26.90% | $1.5M | SEC |
| Q2 2021 | Aug 12, 2021 | −$6.88 | −$5.80 | +15.64% | $540,000.00 | SEC |
| Q1 2021 | May 17, 2021 | −$6.23 | −$15.60 | −150.60% | $371,000.00 | SEC |
| Q4 2020 | Mar 30, 2021 | −$13.23 | −$19.00 | −43.67% | $479,500.00 | SEC |
Quarterly revenue
Frequently asked questions
When did Elicio Therapeutics (ELTX) last report earnings?
Elicio Therapeutics last reported on Nov 13, 2025, covering fiscal Q3 2025.
Did ELTX beat earnings estimates?
No. Elicio Therapeutics reported EPS of −$0.60 for Q3 2025 against a −$0.48 estimate — a 25.00% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.